Quarterly report [Sections 13 or 15(d)]

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

v3.26.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
$ in Thousands
Total
Common Stock
Additional
Paid-in
Capital
Accumulated
Deficit
Beginning balance (in shares) at Dec. 31, 2024   8,656,122    
Beginning balance at Dec. 31, 2024 $ (100,500) $ 1 $ 322,729 $ (423,230)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Issuance of common stock for PIPE Investment, net of issuance costs (in shares)   1,771,586    
Issuance of common stock for PIPE Investment, net of issuance costs 3,477   3,477  
Deemed dividend to Series A Preferred Stock (403)   (403)  
Vesting of restricted stock units, net (in shares)   215,260    
Stock-based compensation 647   647  
Net loss (37,675)     (37,675)
Ending balance (in shares) at Mar. 31, 2025   10,642,968    
Ending balance at Mar. 31, 2025 $ (134,454) $ 1 326,450 (460,905)
Beginning balance (in shares) at Dec. 31, 2025 22,223,800 22,223,800    
Beginning balance at Dec. 31, 2025 $ (166,236) $ 2 351,371 (517,609)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Vesting of restricted stock units, net (in shares)   527,495    
Vesting of restricted stock units, net (99)   (99)  
Stock-based compensation 1,032   1,032  
Net loss $ (12,718)     (12,718)
Ending balance (in shares) at Mar. 31, 2026 22,751,295 22,751,295    
Ending balance at Mar. 31, 2026 $ (178,021) $ 2 $ 352,304 $ (530,327)